More Women Underwent Surgical Sterilization After Fall of Roe v. Wade
By Ernie Mundell HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- As fears of the consequences of an unintended pregnancy rose after Roe v. Wade was overturned in 2022, rates of surgical sterilization rose in those states most affected by the decision, new research shows.
Rates of tubal sterilization -- tying, cutting or removing the fallopian tubes -- rose by an average 3% per month in states where abortion became illegal after the Supreme Court ruling on Dobbs v. Jackson Women’s Health. That trend continued for six months after the June 2022 ruling.
“Our study suggests that the Dobbs ruling and subsequent state laws banning or limiting access to abortion may affect a woman’s choice of contraception,” said lead researcher Xiao Xu, a health outcomes researcher at Columbia University Irving Medical Center in New York City.
She noted that deciding to undergo surgical sterilization can have lifelong consequences for women since it is irreversible.
The new findings were published Sept. 11 in the Journal of the American Medical Association.
Xu's team looked at surgical sterilization rates before and after the Dobbs decision among about 4.8 million women in 36 states and Washington, D.C.
Besides the 3% month-by-month rise in states that banned abortion post-Dobbs, there was a similar uptick in states that restricted access to abortion but did not ban it, although the rise did not reach statistical significance.
No rise in surgical sterilization was observed in states where access to abortion remained unchanged.
One recent study suggests that surgical sterilization is not foolproof.
Researchers at the University of California, San Francisco (UCSF) found that between 3% and 5% of U.S. women who underwent tubal ligation later reported an unplanned pregnancy, according to findings published Aug. 27 in the journal NEJM Evidence.
“This study shows that tubal surgery cannot be considered the best way to prevent pregnancy,” said lead researcher Dr. Eleanor Bimla Schwarz, chief of general internal medicine at UCSF.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-12 05:30
Read more
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- Vitamin D Supplements Could Help Lower Blood Pressure in Obese People
- Current Tobacco Use Declining in U.S. Youth in 2024
- Complete Vaccination Coverage Down in Kindergarteners for 2023-24 School Year
- 1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
- Poor Cardiovascular Health Linked to Composite of Poor Brain Health
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions